Daniel Abdun-Nabi, President & CEO at Emergent BioSolutions Inc. (EBS), sold 63,209 shares at $39.17 ($2.5M) on 2015-12-24, disclosed to the SEC on 2015-12-28.
Scheduled sale ($2.5M) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.99 | 40,354 | $1.6M | 63.7% |
| 2 | $39.17 | 22,855 | $895K | 36.3% |
| Total | $39.06 avg | 63,209 | $2.5M | 100% |
| Filing → |
| EBS | SELL | 2018-09-18 | $1.9M | — | Filing → |
| EBS | SELL | 2018-09-06 | $5.5M | — | Filing → |
| EBS | SELL | 2018-06-07 | $823K | — | Filing → |